Main variables	Main activity, secondary one or a tool necessary for production	Total
Companies that carry out R&D in Biotechnology	Total	1.133
Companies that carry out R&D in Biotechnology	Main	603
Companies that carry out R&D in Biotechnology	Secondary dwellings	173
Companies that carry out R&D in Biotechnology	Tool	357
%Companies according to biotechnology used: Genetic code	Total	33
%Companies according to biotechnology used: Genetic code	Main	39
%Companies according to biotechnology used: Genetic code	Secondary dwellings	28
%Companies according to biotechnology used: Genetic code	Tool	25
%Companies according to biotechnology used: Functional units	Total	41
%Companies according to biotechnology used: Functional units	Main	44
%Companies according to biotechnology used: Functional units	Secondary dwellings	39
%Companies according to biotechnology used: Functional units	Tool	36
%Companies according to biotechnology used: Cellular and tissue culturing and engineering	Total	24
%Companies according to biotechnology used: Cellular and tissue culturing and engineering	Main	29
%Companies according to biotechnology used: Cellular and tissue culturing and engineering	Secondary dwellings	19
%Companies according to biotechnology used: Cellular and tissue culturing and engineering	Tool	17
%Companies according to biotechnology used: Bioprocesses	Total	50
%Companies according to biotechnology used: Bioprocesses	Main	45
%Companies according to biotechnology used: Bioprocesses	Secondary dwellings	42
%Companies according to biotechnology used: Bioprocesses	Tool	61
%Companies according to biotechnology used: Sub-cellular organisms	Total	6
%Companies according to biotechnology used: Sub-cellular organisms	Main	8
%Companies according to biotechnology used: Sub-cellular organisms	Secondary dwellings	5
%Companies according to biotechnology used: Sub-cellular organisms	Tool	3
%Companies according to biotechnology used: Bio-computing	Total	24
%Companies according to biotechnology used: Bio-computing	Main	33
%Companies according to biotechnology used: Bio-computing	Secondary dwellings	19
%Companies according to biotechnology used: Bio-computing	Tool	12
%Companies according to biotechnology used: Nanobiotechnology	Total	13
%Companies according to biotechnology used: Nanobiotechnology	Main	17
%Companies according to biotechnology used: Nanobiotechnology	Secondary dwellings	15
%Companies according to biotechnology used: Nanobiotechnology	Tool	6
%Companies according to biotechnology used: Other	Total	14
%Companies according to biotechnology used: Other	Main	16
%Companies according to biotechnology used: Other	Secondary dwellings	16
%Companies according to biotechnology used: Other	Tool	11
%Company by field(s) of ultimate application of biotechnology use: Human Health	Total	45
%Company by field(s) of ultimate application of biotechnology use: Human Health	Main	59
%Company by field(s) of ultimate application of biotechnology use: Human Health	Secondary dwellings	41
%Company by field(s) of ultimate application of biotechnology use: Human Health	Tool	24
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture	Total	18
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture	Main	21
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture	Secondary dwellings	14
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture	Tool	13
%Company by field(s) of ultimate application of biotechnology use: Food products	Total	31
%Company by field(s) of ultimate application of biotechnology use: Food products	Main	25
%Company by field(s) of ultimate application of biotechnology use: Food products	Secondary dwellings	28
%Company by field(s) of ultimate application of biotechnology use: Food products	Tool	43
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production	Total	22
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production	Main	19
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production	Secondary dwellings	27
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production	Tool	26
%Company by field(s) of ultimate application of biotechnology use: Environment	Total	14
%Company by field(s) of ultimate application of biotechnology use: Environment	Main	11
%Company by field(s) of ultimate application of biotechnology use: Environment	Secondary dwellings	22
%Company by field(s) of ultimate application of biotechnology use: Environment	Tool	13
%Company by field(s) of ultimate application of biotechnology use: Industry	Total	12
%Company by field(s) of ultimate application of biotechnology use: Industry	Main	13
%Company by field(s) of ultimate application of biotechnology use: Industry	Secondary dwellings	16
%Company by field(s) of ultimate application of biotechnology use: Industry	Tool	8
Personnel in R&D in biotechnology (no. of persons)	Total	11.510
Personnel in R&D in biotechnology (no. of persons)	Main	6.862
Personnel in R&D in biotechnology (no. of persons)	Secondary dwellings	1.521
Personnel in R&D in biotechnology (no. of persons)	Tool	3.127
Personnel in R&D in biotechnology (no. of persons): Researchers	Total	6.202
Personnel in R&D in biotechnology (no. of persons): Researchers	Main	3.759
Personnel in R&D in biotechnology (no. of persons): Researchers	Secondary dwellings	900
Personnel in R&D in biotechnology (no. of persons): Researchers	Tool	1.543
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants	Total	5.308
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants	Main	3.103
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants	Secondary dwellings	621
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants	Tool	1.584
Personnel in R&D in biotechnology (no. of persons): women	Total	6.389
Personnel in R&D in biotechnology (no. of persons): women	Main	4.015
Personnel in R&D in biotechnology (no. of persons): women	Secondary dwellings	750
Personnel in R&D in biotechnology (no. of persons): women	Tool	1.624
Personnel in R&D in biotechnology (no. of persons): (women) Researchers	Total	3.304
Personnel in R&D in biotechnology (no. of persons): (women) Researchers	Main	2.079
Personnel in R&D in biotechnology (no. of persons): (women) Researchers	Secondary dwellings	442
Personnel in R&D in biotechnology (no. of persons): (women) Researchers	Tool	783
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants	Total	3.086
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants	Main	1.937
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants	Secondary dwellings	308
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants	Tool	841
Personnel in R&D in biotechnology (FTE)	Total	8.236,9
Personnel in R&D in biotechnology (FTE)	Main	5.430,2
Personnel in R&D in biotechnology (FTE)	Secondary dwellings	989,7
Personnel in R&D in biotechnology (FTE)	Tool	1.817
Personnel in R&D in biotechnology (FTE): Researchers	Total	4.596,1
Personnel in R&D in biotechnology (FTE): Researchers	Main	3.001,4
Personnel in R&D in biotechnology (FTE): Researchers	Secondary dwellings	642,6
Personnel in R&D in biotechnology (FTE): Researchers	Tool	952,1
Personnel in R&D in biotechnology (FTE): Technicians and assistants	Total	3.640,8
Personnel in R&D in biotechnology (FTE): Technicians and assistants	Main	2.428,8
Personnel in R&D in biotechnology (FTE): Technicians and assistants	Secondary dwellings	347,1
Personnel in R&D in biotechnology (FTE): Technicians and assistants	Tool	864,9
Personnel in R&D in biotechnology (FTE): women	Total	4.698,5
Personnel in R&D in biotechnology (FTE): women	Main	3.180,1
Personnel in R&D in biotechnology (FTE): women	Secondary dwellings	503,1
Personnel in R&D in biotechnology (FTE): women	Tool	1.015,3
Personnel in R&D in biotechnology (FTE): (women) Researchers	Total	2.512,5
Personnel in R&D in biotechnology (FTE): (women) Researchers	Main	1.684,7
Personnel in R&D in biotechnology (FTE): (women) Researchers	Secondary dwellings	323,4
Personnel in R&D in biotechnology (FTE): (women) Researchers	Tool	504,4
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants	Total	2.186
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants	Main	1.495,4
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants	Secondary dwellings	179,7
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants	Tool	510,9
Internal expenditure on R&D (thousands of euros)	Total	769.431
Internal expenditure on R&D (thousands of euros)	Main	541.881
Internal expenditure on R&D (thousands of euros)	Secondary dwellings	63.951
Internal expenditure on R&D (thousands of euros)	Tool	163.599
1) By nature of the expense: Current expenses	Total	719.715
1) By nature of the expense: Current expenses	Main	502.430
1) By nature of the expense: Current expenses	Secondary dwellings	60.603
1) By nature of the expense: Current expenses	Tool	156.683
1.1) Remuneration to researchers	Total	221.447
1.1) Remuneration to researchers	Main	151.282
1.1) Remuneration to researchers	Secondary dwellings	26.154
1.1) Remuneration to researchers	Tool	44.011
1.2) Remuneration to technicians and assistants	Total	122.809
1.2) Remuneration to technicians and assistants	Main	83.753
1.2) Remuneration to technicians and assistants	Secondary dwellings	10.469
1.2) Remuneration to technicians and assistants	Tool	28.587
1.3) Other current expenses	Total	375.459
1.3) Other current expenses	Main	267.396
1.3) Other current expenses	Secondary dwellings	23.979
1.3) Other current expenses	Tool	84.084
2) By nature of the expense: Capital expenses	Total	49.715
2) By nature of the expense: Capital expenses	Main	39.451
2) By nature of the expense: Capital expenses	Secondary dwellings	3.348
2) By nature of the expense: Capital expenses	Tool	6.916
2.1) Land and buildings	Total	9.521
2.1) Land and buildings	Main	7.987
2.1) Land and buildings	Secondary dwellings	676
2.1) Land and buildings	Tool	858
2.2) Equipment and instruments	Total	30.466
2.2) Equipment and instruments	Main	22.742
2.2) Equipment and instruments	Secondary dwellings	2.475
2.2) Equipment and instruments	Tool	5.248
2.3) Acquisition of specific R+D software	Total	1.810
2.3) Acquisition of specific R+D software	Main	1.212
2.3) Acquisition of specific R+D software	Secondary dwellings	89
2.3) Acquisition of specific R+D software	Tool	509
2.4) Otros productos de propiedad intelectual específicos para I+D	Total	7.919
2.4) Otros productos de propiedad intelectual específicos para I+D	Main	7.510
2.4) Otros productos de propiedad intelectual específicos para I+D	Secondary dwellings	108
2.4) Otros productos de propiedad intelectual específicos para I+D	Tool	301
1.1) By origin of the funds: Own funds	Total	490.913
1.1) By origin of the funds: Own funds	Main	347.382
1.1) By origin of the funds: Own funds	Secondary dwellings	40.321
1.1) By origin of the funds: Own funds	Tool	103.210
1.2) By origin of the funds: From companies	Total	82.548
1.2) By origin of the funds: From companies	Main	62.516
1.2) By origin of the funds: From companies	Secondary dwellings	5.356
1.2) By origin of the funds: From companies	Tool	14.676
1.3) By origin of the funds: Public Administration funds	Total	96.809
1.3) By origin of the funds: Public Administration funds	Main	67.645
1.3) By origin of the funds: Public Administration funds	Secondary dwellings	12.905
1.3) By origin of the funds: Public Administration funds	Tool	16.259
1.4) By origin of the funds: From Universities	Total	197
1.4) By origin of the funds: From Universities	Main	193
1.4) By origin of the funds: From Universities	Secondary dwellings	0
1.4) By origin of the funds: From Universities	Tool	4
1.5) By origin of the funds: From non profit private institutions	Total	4.766
1.5) By origin of the funds: From non profit private institutions	Main	1.422
1.5) By origin of the funds: From non profit private institutions	Secondary dwellings	0
1.5) By origin of the funds: From non profit private institutions	Tool	3.344
1.6) By origin of the funds: Foreign funds	Total	94.197
1.6) By origin of the funds: Foreign funds	Main	62.723
1.6) By origin of the funds: Foreign funds	Secondary dwellings	5.369
1.6) By origin of the funds: Foreign funds	Tool	26.106
Purchase of R&D services in biotechnology (thousands of euros)	Total	120.281
Purchase of R&D services in biotechnology (thousands of euros)	Main	102.804
Purchase of R&D services in biotechnology (thousands of euros)	Secondary dwellings	9.714
Purchase of R&D services in biotechnology (thousands of euros)	Tool	7.763
Purchase of R&D services in biotechnology (thousands of euros): In Spain	Total	69.564
Purchase of R&D services in biotechnology (thousands of euros): In Spain	Main	57.335
Purchase of R&D services in biotechnology (thousands of euros): In Spain	Secondary dwellings	8.455
Purchase of R&D services in biotechnology (thousands of euros): In Spain	Tool	3.773
Purchase of R&D services in biotechnology (thousands of euros): Abroad	Total	50.718
Purchase of R&D services in biotechnology (thousands of euros): Abroad	Main	45.469
Purchase of R&D services in biotechnology (thousands of euros): Abroad	Secondary dwellings	1.259
Purchase of R&D services in biotechnology (thousands of euros): Abroad	Tool	3.990
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital	Total	45
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital	Main	52
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital	Secondary dwellings	42
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital	Tool	35
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information	Total	12
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information	Main	9
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information	Secondary dwellings	17
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information	Tool	16
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources	Total	16
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources	Main	14
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources	Secondary dwellings	20
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources	Tool	18
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain	Total	14
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain	Main	14
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain	Secondary dwellings	16
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain	Tool	12
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of access to international markets	Total	16
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of access to international markets	Main	16
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of access to international markets	Secondary dwellings	20
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of access to international markets	Tool	14
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of distribution and sales channels	Total	18
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of distribution and sales channels	Main	20
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of distribution and sales channels	Secondary dwellings	18
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of distribution and sales channels	Tool	16
%Companies that consider the following obstacles as very important considering biotechnology development : Acceptance / public perception	Total	15
%Companies that consider the following obstacles as very important considering biotechnology development : Acceptance / public perception	Main	15
%Companies that consider the following obstacles as very important considering biotechnology development : Acceptance / public perception	Secondary dwellings	18
%Companies that consider the following obstacles as very important considering biotechnology development : Acceptance / public perception	Tool	15
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements	Total	37
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements	Main	39
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements	Secondary dwellings	38
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements	Tool	32
%Companies that consider the following obstacles as very important considering biotechnology development : Time / cost	Total	52
%Companies that consider the following obstacles as very important considering biotechnology development : Time / cost	Main	54
%Companies that consider the following obstacles as very important considering biotechnology development : Time / cost	Secondary dwellings	56
%Companies that consider the following obstacles as very important considering biotechnology development : Time / cost	Tool	46
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting	Total	20
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting	Main	20
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting	Secondary dwellings	21
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting	Tool	20
% Companies that have requested biotechnology patents	Total	15
% Companies that have requested biotechnology patents	Main	21
% Companies that have requested biotechnology patents	Secondary dwellings	11
% Companies that have requested biotechnology patents	Tool	7
Number of patents requested	Total	681
Number of patents requested	Main	485
Number of patents requested	Secondary dwellings	100
Number of patents requested	Tool	96
% Companies with income of an international origin related to biotechnological activities	Total	24,3
% Companies with income of an international origin related to biotechnological activities	Main	34,1
% Companies with income of an international origin related to biotechnological activities	Secondary dwellings	12,6
% Companies with income of an international origin related to biotechnological activities	Tool	13,5
% Turnover representing income of an international origin related to biotechnological activities	Total	1
% Turnover representing income of an international origin related to biotechnological activities	Main	9
% Turnover representing income of an international origin related to biotechnological activities	Secondary dwellings	0
% Turnover representing income of an international origin related to biotechnological activities	Tool	1
% Income of of an international origin related to biotechnological activities distributed in: Income received from the EU	Total	59,6
% Income of of an international origin related to biotechnological activities distributed in: Income received from the EU	Main	60,2
% Income of of an international origin related to biotechnological activities distributed in: Income received from the EU	Secondary dwellings	79,3
% Income of of an international origin related to biotechnological activities distributed in: Income received from the EU	Tool	54,7
% Income of of an international origin related to biotechnological activities distributed in: Income received from other countries	Total	40,4
% Income of of an international origin related to biotechnological activities distributed in: Income received from other countries	Main	39,8
% Income of of an international origin related to biotechnological activities distributed in: Income received from other countries	Secondary dwellings	20,7
% Income of of an international origin related to biotechnological activities distributed in: Income received from other countries	Tool	45,4
% Income of of an international origin related to biotechnological activities by classification: Internacional trade in products and services	Total	80,4
% Income of of an international origin related to biotechnological activities by classification: Internacional trade in products and services	Main	78,5
% Income of of an international origin related to biotechnological activities by classification: Internacional trade in products and services	Secondary dwellings	17,9
% Income of of an international origin related to biotechnological activities by classification: Internacional trade in products and services	Tool	96,8
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain	Total	16,5
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain	Main	19,3
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain	Secondary dwellings	0,6
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain	Tool	1,4
% Income of an international origin related with activities according to the classification: Operating source abroad	Total	2,2
% Income of an international origin related with activities according to the classification: Operating source abroad	Main	1,3
% Income of an international origin related with activities according to the classification: Operating source abroad	Secondary dwellings	70,4
% Income of an international origin related with activities according to the classification: Operating source abroad	Tool	1,8
% Income of an international origin related with activities according to the classification: Other	Total	0,9
% Income of an international origin related with activities according to the classification: Other	Main	0,9
% Income of an international origin related with activities according to the classification: Other	Secondary dwellings	11,1
% Income of an international origin related with activities according to the classification: Other	Tool	0